Perioperative Infection Control and Antibiotic Prophylaxis for Ventriculoperitoneal Shunt Insertion

Infection associated with ventriculoperitoneal (VP) shunt insertion is a problem faced by many hydrocephalus patients, often caused by gram-positive bacteria. Research has identified infection rates in neonatal and pediatric patients, and frequent procedural errors that raise the risk of infection; but the effectiveness of specific antibiotic treatments and protocols requires further exploration. This study evaluates antibiotic prophylaxis and perioperative infection control to determine the most effective preventative measures in reducing the infection rate in VP shunt insertion procedures by analyzing existing literature and comparing infection outcomes in patients. A literature review was conducted to examine the success of perioperative procedures implemented for VP shunt insertion among neonatal and pediatric patients. A total of 80 articles from PubMed were screened and 35 were selected for detailed analysis based on relevance, success rate, patient outcome, and infection incidence rates. Findings suggest that infections remain the primary complication of VP shunt insertion, but standardized protocols, antibiotics, and perioperative procedures can significantly reduce infection rates. Cephalosporin prophylaxis has been particularly effective, with a lower infection rate (3.8%) compared to cloxacillin (12.7% infection rate), due to its broad-spectrum activity against gram-positive bacteria. Patients undergoing revision surgeries experience a higher infection rate (4.8%) due to increased exposure, allowing bacteria to colonize open shunts. Cephalosporin targets Staphylococcus aureus, while cloxacillin targets Staphylococcus epidermidis, providing antimicrobial activity against these pathogens responsible for shunt-related infections. Implementing effective antibiotic treatments and protocols in insertion surgeries is crucial in reducing complications and improving long-term patient outcomes.